Chronic fluoxetine treatment induces lipid accumulation but does not alter the expression of Pref-1 in rat adipose tissue

1. S. Adams, D. Heckard, J. Hassell and L. Uphouse, Factors influencing fluoxetine-induced sexual dysfunction in female rats, Behav. Brain Res. 235 (2012) 73-81; https://doi.org/10.1016/j.bbr.2012.07.02910.1016/j.bbr.2012.07.029343267822835821Search in Google Scholar

2. M. Afkhami-Ardekani and H. Sedghi, Effect of fluoxetine on weight reduction in obese patients, Indian J. Clin. Biochem. 20 (2005) 135-138.10.1007/BF02893059345417523105511Search in Google Scholar

3. S. R. Blumenthal, V. M. Castro, C. C. Clements, H. R. Rosenfield, S. N. Murphy, M. Fava, J. B. Weilburg, J. L. Erb, S. E. Churchill, I. S. Kohane, J. W. Smoller and R. H. Perlis, An electronic health records study of long-term weight gain following antidepressant use, JAMA Psychiatry 71 (2014) 889-896; https://doi.org/10.1001/jamapsychiatry.2014.41410.1001/jamapsychiatry.2014.41424898363Search in Google Scholar

4. J. P. Domecq, G. Prutsky, A. Leppin, M. B. Sonbol, O. Altayar, C. Undavalli, Z. Wang, T. Elraiyah, J. P. Brito, K. F. Mauck, M. H. Lababidi, L. J Prokop, N. Asi, J. Wei, S. Fidahussein, V. M. Montori and M. H. Murad, Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis, J. Clin. Endocrinol. Metab. 100 (2015) 363-370; https://doi.org/10.1210/jc.2014-342110.1210/jc.2014-3421539350925590213Search in Google Scholar

5. C. S. Hudak and H. S. Sul, Pref-1, a gatekeeper of adipogenesis, Front. Endocrinol. 4 (2013) 1-6; https://doi.org/10.3389/fendo.2013.0007910.3389/fendo.2013.00079369971423840193Search in Google Scholar

6. S. Caccia, M. Cappi, C. Fracasso and S. Garattini, Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat, Psychopharmacology (Berlin) 100 (1990) 509-514.10.1007/BF022440042320712Search in Google Scholar

7. N. W. Jacobsen, C. H. Hansen, C. Nellemann, B. Styrishave and B. Halling-Sørensen, Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay, Toxicol. in Vitro 29 (2015) 1729-1735; https://doi.org/10.1016/j.tiv.2015.07.00510.1016/j.tiv.2015.07.00526162595Search in Google Scholar

8. B. K. Sun, J. H. Kim, J. S. Choi, S. J. Hwang and J. H. Sung, Fluoxetine decreases the proliferation and adipogenic differentiation of human adipose-derived stem cells, Int. J. Mol. Sci. 16 (2015) 16655-16668; https://doi.org/10.3390/ijms16071665510.3390/ijms160716655451997126204837Search in Google Scholar

9. M. Kolcsár, Z. Gáll, I. L. Bíró, L. I. Bába, A. Imre, M. T. Dogaru and O. Martha, Fluoxetine influence on body weight, serum adiponectin level and adipose tissue triglycerides levels in rats, Farmacia 6 (2016) 599-604.Search in Google Scholar

10. A. K. Stunes, J. E. Reseland, O. Hauso, M. Kidd, K. Tommeras, H. L. Waldum, U. Syversen and B. I. Gustafsson, Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation, Diabetes Obes. Metab. 13 (2011) 551-558; https://doi.org/10.1111/j.1463-1326.2011.01378.x10.1111/j.1463-1326.2011.01378.x21320265Search in Google Scholar

11. S. Grès, S. Canteiro, J. Mercader and C. Carpéné, Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells, Mol. Nutr. Food Res. 57 (2013) 1089-1099; https://doi.org/10.1002/mnfr.20120068110.1002/mnfr.20120068123390020Search in Google Scholar

12. S. Grès, S. Gomez-Zorita, A Gomez-Ruiz and C. Carpene, 5-Hydroxytryptamine actions in adipocytes: involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation, J. Neural. Transm. (Vienna) 120 (2013) 919-926; https://doi.org/10.1007/s00702-012-0959-810.1007/s00702-012-0959-823271029Search in Google Scholar